Metropolis Healthcare (NSE:METROPOLIS) Debt-to-Equity : N/A (As of Dec. 2024)

View and export this data going back to 2019. Start your Free Trial

What is Metropolis Healthcare Debt-to-Equity?

Metropolis Healthcare's Short-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Metropolis Healthcare's Long-Term Debt & Capital Lease Obligation for the quarter that ended in Dec. 2024 was ₹0 Mil. Metropolis Healthcare's Total Stockholders Equity for the quarter that ended in Dec. 2024 was ₹0 Mil.

A high debt to equity ratio generally means that a company has been aggressive in financing its growth with debt. This can result in volatile earnings as a result of the additional interest expense.

The historical rank and industry rank for Metropolis Healthcare's Debt-to-Equity or its related term are showing as below:

NSE:METROPOLIS' s Debt-to-Equity Range Over the Past 10 Years
Min: 0 Med: 0.14 Max: 0.43
Current: 0.16

During the past 9 years, the highest Debt-to-Equity Ratio of Metropolis Healthcare was 0.43. The lowest was 0.00. And the median was 0.14.

NSE:METROPOLIS's Debt-to-Equity is ranked better than
61.98% of 192 companies
in the Medical Diagnostics & Research industry
Industry Median: 0.23 vs NSE:METROPOLIS: 0.16

Metropolis Healthcare Debt-to-Equity Historical Data

The historical data trend for Metropolis Healthcare's Debt-to-Equity can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Metropolis Healthcare Debt-to-Equity Chart

Metropolis Healthcare Annual Data

Trend

Mar16

Mar17

Mar18

Mar19

Mar20

Mar21

Mar22

Mar23

Mar24

Debt-to-Equity

Get a 7-Day Free Trial

0.13

0.16

0.43

0.27

0.18

Metropolis Healthcare Quarterly Data
	Mar20	Jun20	Sep20	Dec20	Mar21	Jun21	Sep21	Dec21	Mar22	Jun22	Sep22	Dec22	Mar23	Jun23	Sep23	Dec23	Mar24	Jun24	Sep24	Dec24
Debt-to-Equity	Get a 7-Day Free Trial															N/A	0.18	N/A	0.16	N/A

Competitive Comparison of Metropolis Healthcare's Debt-to-Equity

For the Diagnostics & Research subindustry, Metropolis Healthcare's Debt-to-Equity, along with its competitors' market caps and Debt-to-Equity data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.

Metropolis Healthcare's Debt-to-Equity Distribution in the Medical Diagnostics & Research Industry

For the Medical Diagnostics & Research industry and Healthcare sector, Metropolis Healthcare's Debt-to-Equity distribution charts can be found below:

* The bar in red indicates where Metropolis Healthcare's Debt-to-Equity falls into.

Save Embed

;

Save Embed

;

Metropolis Healthcare Debt-to-Equity Calculation

Debt to Equity measures the financial leverage a company has.

Metropolis Healthcare's Debt to Equity Ratio for the fiscal year that ended in Mar. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(779.967	+	1190.678)	/	10961.555
	=	0.18

Metropolis Healthcare's Debt to Equity Ratio for the quarter that ended in Dec. 2024 is calculated as

Debt to Equity	=	Total Debt			/	Total Stockholders Equity
	=	(Short-Term Debt & Capital Lease Obligation	+	Long-Term Debt & Capital Lease Obligation)	/	Total Stockholders Equity
	=	(0	+	0)	/	0
	=	N/A

Metropolis Healthcare (NSE:METROPOLIS) Debt-to-Equity Explanation

In the calculation of Debt to Equity, we use the total of Short-Term Debt & Capital Lease Obligation and Long-Term Debt & Capital Lease Obligation divided by Total Stockholders Equity. In some calculations, Total Liabilities is used to for calculation.

Be Aware

Because a company can increase its ROE % by having more financial leverage, it is important to watch the leverage ratio when investing in high ROE % companies.

Metropolis Healthcare Debt-to-Equity Related Terms

Thank you for viewing the detailed overview of Metropolis Healthcare's Debt-to-Equity provided by GuruFocus.com. Please click on the following links to see related term pages.

Metropolis Healthcare Business Description

Industry

GURUFOCUS.COM » STOCK LIST » Healthcare » Medical Diagnostics & Research » Metropolis Healthcare Ltd (NSE:METROPOLIS) » Definitions » Debt-to-Equity

Comparable Companies

Traded in Other Exchanges

542650:India

Address

Dr. Annie Besant Road, 4th Floor, East Wing, Plot-254 B, Nirlon House, Worli, Mumbai, MH, IND, 400 030

Website

https://www.metropolisindia.com

Metropolis Healthcare Ltd is a diagnostic company in India. It offers a comprehensive range of clinical laboratory tests and profiles, which are used for the prediction, early detection, diagnostic screening, confirmation, and monitoring of the disease. It also offers analytical and supports services to clinical research organizations for their clinical research projects. Pathology service is the only principal activity and reportable segment from which the Group generates its revenue.

Metropolis Healthcare Headlines

No Headlines